ONCE-WEEKLY
DOSING

EASE
OF USE

Getting patients started with flexible once-weekly Ozempic®1

START

STEP

STAY

0.25 mg

0.5 mg

0.5 mg or 1 mg

for

for at least

based on individual

4 weeks*

4 weeks

glycaemic control

Start patients off right with a prescription for 0.25 mg for
4 weeks followed by 0.5 mg for another 4 weeks

Ozempic® is available in pre-filled, multi-use pens.
NovoFine® Plus 4-mm needles are included
with every Ozempic® pen.

WITH OR WITHOUT MEALS

Ozempic® 0.25 mg

QW for 4 weeks

Ozempic® 0.5 mg

QW for 4 weeks

*The starting dose of 0.25 mg is not a maintenance dose and is intended to help patients adjust to treatment.

ONCE-WEEKLY
DOSING

EASE
OF USE

Ozempic®—initiation begins with a few simple steps1

DIAL

DOSE

DONE

Dial to the prescribed dose

Ozempic® can be taken in the abdomen, thigh or upper arm

THE THINNEST NEEDLE AVAILABLE

WITH A ONCE-WEEKLY GLP-1 RA22

NovoFine® Plus 32G 4-mm needle
compared with 2 human hairs23

GLP-1 RA=glucagon-like peptide-1 receptor agonist.

HOW-TO-USE VIDEO

HOW-TO-USE VIDEO

SATISFACTION

SATISFACTION

x

A user-friendly pen embraced by patients worldwide24*†

98.5%

FOUND IT EASY TO USE*

1.5 MILLION

PATIENTS USE THE FLEXTOUCH® PEN†

Result do not specifically apply to the Ozempic® pen.

*Data based on a 26-week, multicentre, open-label, randomised, treat-to-target study that included an

insulin-naïve patient population and evaluated the pen with insulin using specific device questions.

†The Ozempic® pen is built on the FlexTouch® platform used for other Novo Nordisk products. IQVIA MAT October 2017.